Amedisys (AMED) PT Lowered to $210 at Raymond James
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $90.40 -0.42%
Rating Summary:
8 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
8 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Raymond James analyst John Ransom lowered the price target on Amedisys (NASDAQ: AMED) to $210.00 (from $225.00) while maintaining a Outperform rating.
You May Also Be Interested In
- QuantumScape (QS) PT Lowered to $6 at Truist Securities
- Shopify (SHOP) stock rating raised at Morgan Stanley
- Synovus Financial (SNV) PT Lowered to $42 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
